Jasleen Randhawa, MD

Assistant Professor of Clinical Medicine in Oncology, Institute for Academic Medicine
Houston Methodist
Weill Cornell Medical College


Areas Of Expertise

Hematology Leukemia Lymphoma
Publications

Final outcomes of escalated melphalan 280 mg/m2 with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high CR and VGPR rates do not translate into improved survival
Hari, P, Reece, DE, Randhawa, J, Flomenberg, N, Howard, DS, Badros, AZ, Rapoport, AP, Meisenberg, BR, Filicko-Ohara, J, Phillips, GL & Vesole, DH 2018, Bone Marrow Transplantation, pp. 1-7. https://doi.org/10.1038/s41409-018-0261-y

A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia
Abou Dalle, I, Cortes, JE, Pinnamaneni, P, Lamothe, B, Diaz Duque, A, Randhawa, J, Pemmaraju, N, Jabbour, E, Ferrajoli, A, Wierda, WG, Estrov, Z, Konopleva, M, Ravandi, F, Alvarado, Y, Borthakur, G, Gandhi, V & Kantarjian, HM 2018, Acta Haematologica, pp. 30-39. https://doi.org/10.1159/000490092

An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes
Daher, M, Hidalgo Lopez, JE, Randhawa, J, Jabbar, KJ, Wei, Y, Pemmaraju, N, Borthakur, G, Kadia, T, Konopleva, M, Kantarjian, HM, Hearn, K, Estrov, Z, Reyes, S, Bueso-Ramos, CE & Garcia-Manero, G 2017, American Journal of Hematology, vol. 92, no. 7, pp. 674-682. https://doi.org/10.1002/ajh.24746

A review of supportive care and recommended preventive approaches for patients with chronic lymphocytic leukemia
Randhawa, J & Ferrajoli, A 2016, Expert Review of Hematology, vol. 9, no. 3, pp. 235-244. https://doi.org/10.1586/17474086.2016.1129893

Allogeneic hematopoietic cell transplantation in multiple myeloma
Randhawa, J, Singh, V & Hari, P 2014, . in Cancer Consult: Expertise for Clinical Practice. Wiley, pp. 381-387. https://doi.org/10.1002/9781118589199.ch60

Clinical regression of squamous cell carcinoma and keratoacanthomas in a patient treated with a hypomethylating agent
Randhawa, J, Wong, S, Atallah, E & Olasz, E 2014, International Journal of Dermatology, vol. 53, no. 1. https://doi.org/10.1111/j.1365-4632.2011.05350.x

Splenomegaly in myelofibrosis-new options for therapy and the therapeutic potential of Janus kinase 2 inhibitors
Randhawa, J, Ostojic, A, Vrhovac, R, Atallah, E & Verstovsek, S 2012, Journal of Hematology and Oncology, vol. 5, 43. https://doi.org/10.1186/1756-8722-5-43